Norges Bank
KNSA icon

Norges Bank’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Norges Bank’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,947
Closed -$406K – 2235
2021
Q1 		$406K Sell
21,947
-45,649
-68% -$934K ﹤0.01% 2099
2020
Q4 		$1.19M Sell
67,596
-55,625
-45% -$977K ﹤0.01% 2011
2020
Q3 		$1.89M Buy
123,221
+82,395
+202% +$1.55M ﹤0.01% 1973
2020
Q2 		$1.04M Buy
40,826
+22,750
+126% +$475K ﹤0.01% 2008
2020
Q1 		$280K Buy
+18,076
New +$283K ﹤0.01% 2034

Other funds holding KNSA

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.6B AUM 47.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return